Releaf is a medical cannabis provider focused on helping eligible patients access regulated treatment with trusted clinical support. The brand combines specialist healthcare with technology designed to make accessing medication more secure and discreet. Its clinical team includes specialist doctors, GPs, and nursing staff, who offer guidance from initial consultation onward and provide care for a range of conditions.

Releaf says it supports a growing community of more than 200,000 people and serves patients across several European markets, including the United Kingdom, Germany, Greece, Switzerland, Denmark, Poland, the Czech Republic, France, and Italy. The availability of treatment and products depends on eligibility and location; the company specifically highlights access to its medical cannabis products and specialist advice for eligible patients in the UK and Germany.

Its offering includes clinical consultations, personalised guidance, and access to a range of high-quality medical cannabis products through a regulated and consistent supply. Releaf’s stated aim is to expand access to reliable treatment while keeping patient care at the centre of its service.